Commonwealth Equity Services
DMRA

Commonwealth Equity Services’s Damora Therapeutics, Inc. Ordinary Shares DMRA Stock Holding History

Commonwealth Equity Services’s Portfolio DMRA Stock Details DMRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-641
Closed -$8K – 4123
2024
Q2 		$8K Sell
641
-259
-29% -$4.09K ﹤0.01% 4006
2024
Q1 		$18K Buy
900
+217
+32% +$3.86K ﹤0.01% 3968
2023
Q4 		$12K Sell
683
-42
-6% -$646 ﹤0.01% 3850
2023
Q3 		$13K Buy
725
+247
+52% +$9.7K ﹤0.01% 3765
2023
Q2 		$30K Buy
478
+71
+17% +$3.87K ﹤0.01% 3720
2023
Q1 		$20 Hold
407
– – ﹤0.01% 3668
2022
Q4 		$11K Hold
407
– – ﹤0.01% 3638
2022
Q3 		$19K Buy
+407
New +$20.6K ﹤0.01% 3585

Other funds holding DMRA

NHAS
Novo Holdings A/S Hellerup, Denmark $1.23B AUM 81.32% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
HI
Harbour Investments Madison, Wisconsin $6.48B AUM 18.23% 1-Year Est. Return
DB
Danske Bank Copenhagen K, Denmark $41.5B AUM 29.19% 1-Year Est. Return
Group One Trading
Group One Trading Chicago, Illinois $52.2B AUM 104.56% 1-Year Est. Return

Commonwealth Equity Services's DMRA Position: Q3 2024 in Review

Commonwealth Equity Services sold out of Damora Therapeutics, Inc. Ordinary Shares (DMRA) in Q3 2024, closing a stake of 641 shares — an estimated $8K sold.

Commonwealth Equity Services first reported a position in DMRA in Q3 2022 and held it in 8 quarters. The position peaked at $30K in Q2 2023. 10 funds tracked by Wall St. Rank hold DMRA as of Q3 2024.

  • Commonwealth Equity Services reported no remaining Damora Therapeutics, Inc. Ordinary Shares position as of Q3 2024 after selling out during the quarter.
  • Commonwealth Equity Services sold 641 Damora Therapeutics, Inc. Ordinary Shares shares in Q3 2024, an estimated $8K.
  • Commonwealth Equity Services first reported a position in Damora Therapeutics, Inc. Ordinary Shares in Q3 2022 and held it in 8 quarters.
  • Commonwealth Equity Services's Damora Therapeutics, Inc. Ordinary Shares position peaked at $30K in Q2 2023.
  • 10 funds tracked by Wall St. Rank held Damora Therapeutics, Inc. Ordinary Shares as of Q3 2024.

Based on Commonwealth Equity Services's 13F filing for Q3 2024, filed 18 Oct 2024.